ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$59.66 USD
-0.72 (-1.19%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $59.68 +0.02 (0.03%) 7:58 PM ET
1-Strong Buy of 5 1
C Value C Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 1.07 |
EPS Last Quarter | 1.02 |
Last EPS Surprise | 9.68% |
ABR | 1.60 |
Earnings ESP
|
0.23% |
---|---|
Current Year | 4.80 |
Next Year | 5.75 |
EPS (TTM) | 4.50 |
P/E (F1) | 12.58 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 141.13M | 152.08M | 568.28M | 626.30M |
# of Estimates | 4 | 3 | 3 | 3 |
High Estimate | 144.50M | 172.20M | 592.10M | 715.30M |
Low Estimate | 138.23M | 140.55M | 554.24M | 552.01M |
Year ago Sales | 131.83M | 131.65M | 486.82M | 568.28M |
Year over Year Growth Est. | 7.06% | 15.52% | 16.73% | 10.21% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.07 | 1.42 | 4.80 | 5.75 |
# of Estimates | 4 | 1 | 1 | 1 |
Most Recent Consensus | 1.07 | NA | NA | NA |
High Estimate | 1.15 | 1.42 | 4.80 | 5.75 |
Low Estimate | 0.99 | 1.42 | 4.80 | 5.75 |
Year ago EPS | 1.27 | 1.00 | 4.71 | 4.80 |
Year over Year Growth Est. | -15.75% | 42.00% | 1.91% | 19.79% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 1 | 1 | 1 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.07 | 1.42 | 4.80 | 5.75 |
7 Days Ago | 1.08 | 1.29 | 4.64 | 5.14 |
30 Days Ago | 1.10 | 1.29 | 4.64 | 5.14 |
60 Days Ago | 1.09 | 1.24 | 4.49 | 5.34 |
90 Days Ago | 1.10 | 1.24 | 4.49 | 5.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.07 | 1.42 | 4.80 | 5.75 |
Zacks Consensus Estimate | 1.07 | 1.42 | 4.80 | 5.75 |
Earnings ESP | 0.23% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.02 | 1.21 | 1.00 | 1.27 | NA |
Estimate | 0.93 | 0.98 | 0.80 | 0.76 | NA |
Difference | 0.09 | 0.23 | 0.20 | 0.51 | 0.26 |
Surprise | 9.68% | 23.47% | 25.00% | 67.11% | 31.32% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more